🇺🇸 FDA
Patent

US 11318196

Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein

granted A61KA61K2039/5252A61K2039/5254

Quick answer

US patent 11318196 (Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/5252, A61K2039/5254, A61K2039/5256, A61K2039/54